![Kang-Yong Pierre](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kang-Yong Pierre
Vertrieb & Marketing bei NKMAX CO., LTD.
Ursprung des Netzwerks ersten Grades von Kang-Yong Pierre
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 17 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kang-Yong Pierre
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Yonsei University | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal | |
Korea University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Seoul National University | College/University | Graduate Degree Graduate Degree | |
Atgen H&D
![]() Atgen H&D Pharmaceuticals: OtherHealth Technology Atgen H&D develops protein products. Sang-Woo Park has been the CEO of the South Korean company since 2016. | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member | |
Texas Tech University | College/University | Doctorate Degree Doctorate Degree | |
NKGen Biotech, Inc.
![]() NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
TIUMBIO CO., LTD. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
ADM KOREA INC. | Medical/Nursing Services | Director/Board Member | |
George Washington University School of Medicine & Health | College/University | Doctorate Degree | |
The University of Chicago | College/University | Undergraduate Degree | |
PeproMene Bio, Inc.
![]() PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
Fuse Biotherapeutics, Inc.
![]() Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Biotechnology | Founder | |
JOONGANG ADVANCED MATERIALS CO., LTD | Computer Communications | Director/Board Member | |
Mercy Corps
![]() Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Services to the Health Industry | Director/Board Member | |
Gideons Promise, Inc. | Director/Board Member | ||
Sungkyunkwan University | College/University | Undergraduate Degree | |
LaMeditech Co. Ltd.
![]() LaMeditech Co. Ltd. Medical SpecialtiesHealth Technology LaMeditech Co. Ltd. engages in the development and manufacturing of laser blood samplers and laser medical devices. Its products include laser blood samplers and laser curing equipment. The company was founded on January 25, 2012 and is headquartered in Seoul, South Korea. | Medical Specialties | Director of Finance/CFO | |
IMARKETKOREA INC. | Internet Retail | Chief Tech/Sci/R&D Officer | |
BIO-SYNECTICS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
J WAY CO., LTD. | Movies/Entertainment | Chief Executive Officer | |
Hankyong National University | College/University | Graduate Degree | |
Gachon University | College/University | Undergraduate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Wonkwang University | College/University | Undergraduate Degree | |
Chungnam National University | College/University | Doctorate Degree | |
PHARMICELL CO., LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
T SCIENTIFIC CO.,LTD. | Major Telecommunications | Director/Board Member | |
HANALL BIOPHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Nkmax Japan, Inc. | Chief Executive Officer | ||
Atgen Japan | Chief Executive Officer | ||
coAsia Biotech Corp.
![]() coAsia Biotech Corp. BiotechnologyHealth Technology Part of NKMAX Co., Ltd. (South Korea), coAsia Biotech Corp. manufactures biological products. Sang-Woo Park has been the CEO of the Thai company since 2016. coAsia Biotech was acquired by NKMAX Co., Ltd. (South Korea) on February 28, 2018 for $0.10 million. | Biotechnology | Chief Executive Officer | |
Nkmax H&D Co. Ltd. | Chief Executive Officer | ||
NKMAX Co., Ltd.
![]() NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Pharmaceuticals: Major | Chief Executive Officer | |
ATGen Canada, Inc. | Chief Executive Officer | ||
ATGen America, Inc. | Chief Executive Officer | ||
TONG YANG LIFE INSURANCE CO., LTD. | Life/Health Insurance | Chief Investment Officer |
Statistik
International
Südkorea | 23 |
Vereinigte Staaten | 11 |
Japan | 3 |
Thailand | 2 |
Kanada | 2 |
Sektoral
Consumer Services | 14 |
Health Technology | 12 |
Health Services | 3 |
Electronic Technology | 2 |
Retail Trade | 2 |
Operativ
Director/Board Member | 27 |
Chief Executive Officer | 14 |
Chairman | 12 |
Undergraduate Degree | 12 |
Doctorate Degree | 7 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Sang-Woo Park | 13 |
Paul Y. Song | 9 |
Jong-Yoon Lee | 5 |
Ki-Jong Hong | 4 |
Yong-Man Kim | 4 |
Jong-Sun Kim | 4 |
Chung-Kyo Park | 4 |
Jae-Ho Cheong | 4 |
Chang-Wook Jang | 4 |
Ho-Geun Yoon | 3 |
Jun-Yong Song | 3 |
Yong-Hwan Cho | 3 |
Jeong-Heon Cha | 2 |
Seung-Ju Ham | 2 |
Kyung-Mo Gu | 2 |
- Börse
- Insiders
- Kang-Yong Pierre
- Unternehmensverbindungen